Skip to main content English


Niema Kazem
Niema Kazem, MD

Department of Medicine II (Division of Cardiology)
Position: Doctor-in-training

ORCID: 0000-0002-6368-4580
T +43 1 40400 73516

Further Information


Acute Coronary Syndrome; Atrial Fibrillation; Cardiopulmonary Resuscitation; Immunity, Cellular; T-Lymphocytes

Selected publications

  1. Kazem, N. et al., 2021. The Prognostic Potential of Growth Differentiation Factor-15 on Bleeding Events and Patient Outcome after Cardiac Surgery – A prospective cohort study. Thrombosis and Haemostasis. Available at:
  2. Kazem, N., Sulzgruber, P. & Niessner, A., 2021. Dosage of direct oral anticoagulants during dual and triple antithrombotic therapy: a focus on the net clinical benefit. European Heart Journal - Cardiovascular Pharmacotherapy. Available at:
  3. Kazem, N. et al., 2020. The Age-Specific Impact of Cellular Immunity on Long-Term Outcome after Acute Coronary Syndrome. Thrombosis and Haemostasis, 121(09), pp.1246–1254. Available at:
  4. Kazem, N. et al., 2020. CD8+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery. Thrombosis and Haemostasis, 120(08), pp.1182–1187. Available at:
  5. Hofer, F., Kazem, N. et al., 2020. Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies. European Heart Journal - Cardiovascular Pharmacotherapy, 7(3), pp.189–195. Available at: